Announcements Trials
Browse Landscape

Phase

Phase 1 3

Status

Completed 2Unknown 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 5Thoracic 4Other solid neoplasm 3Gastrointestinal 2

Conditions

Advanced Malignant Solid Tumors 3

Interventions

Cisplatin 145pembrolizumab 129Carboplatin 125Injections 108Pemetrexed 97Paclitaxel 97Gemcitabine 85Irinotecan 75Nivolumab 71Cyclophosphamide 71Docetaxel 68Bevacizumab 57Oxaliplatin 49Fluorouracil 48atezolizumab 46Capecitabine 46Etoposide 42Leucovorin 41tislelizumab 40toripalimab 36fludarabine 32Ipilimumab 30Drug Therapy 30Topotecan 29durvalumab 28Vincristine 27Early Intervention, Educational 27Radiotherapy 26Interviews as Topic 26Specimen Handling 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × vorolanib × Other solid neoplasm × Clear all
NCT03792958 2022-11-14

Study of Challenge Meditech 082 (CM082) Tablets in Patients With Advanced Malignant Solid Tumors

AnewPharma

Phase 1 Unknown
19 enrolled
Other solid neoplasm

Advanced Malignant Solid Tumors

NCT04328506 2021-11-26

Bioequivalency Study of CM082 Tablet in Healthy Volunteers

AnewPharma

Phase 1 Completed
96 enrolled
Other solid neoplasm

Advanced Malignant Solid Tumors

NCT04126668 2020-05-21

A Study to Investigate the Food Effect on the Pharmacokinetics of CM082 Tablet in Chinese Healthy Volunteers

AnewPharma

Phase 1 Completed
24 enrolled
Other solid neoplasm

Advanced Malignant Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡